Diffuse alveolar haemorrhage
Bleeding into the air sacs of both lungs, often from vasculitis or autoimmune disease, causing breathlessness and anaemia. It is a medical emergency.
Quick facts
- Key signs
- Breathlessness · Cough · Haemoptysis
- Diagnosis
- Kidney or lung biopsy
Red flags ↓
No doses: the clinician sets them by the current guideline.
What it is
Bleeding into the alveolar spaces from injury to the alveolar capillaries, arterioles and venules, defined by diffuse infiltrates on imaging, falling haemoglobin and hypoxaemia, with progressively bloodier bronchoalveolar lavage. It is a syndrome with immune and non-immune causes, not a single disease.
Who gets it
Uncommon but life-threatening. Small-vessel vasculitis (granulomatosis with polyangiitis, microscopic polyangiitis), anti-GBM disease and lupus are the main immune causes; anti-GBM disease peaks in young men and in older adults. In hospital, coagulopathy, heart disease and bone marrow transplantation are frequent non-immune causes.
Causes
- Pulmonary capillaritis: ANCA-associated vasculitis (granulomatosis with polyangiitis, microscopic polyangiitis), systemic lupus erythematosus, antiphospholipid syndrome
- Anti-glomerular basement membrane (anti-GBM) disease: Goodpasture syndrome
- Bland haemorrhage: coagulopathy or anticoagulants, mitral stenosis and left heart failure
- Diffuse alveolar damage: drugs, inhaled cocaine, infections, bone marrow transplantation
- Idiopathic pulmonary haemosiderosis (mainly children)
Risk factors
- Known vasculitis or lupus
- Smoking and inhaled toxins (raise the risk of lung bleeding in anti-GBM disease)
- Inhaled cocaine
- Anticoagulation, thrombocytopenia or coagulopathy
- Haematopoietic stem cell transplantation
- Drugs such as propylthiouracil, hydralazine and levamisole-adulterated cocaine (ANCA-positive vasculitis)
Pathophysiology
A trigger: immune (ANCA vasculitis, anti-GBM antibodies, lupus, antiphospholipid syndrome), bland (coagulopathy, anticoagulants, mitral stenosis) or diffuse alveolar damage (drugs, cocaine, infection, bone marrow transplant) → injury to the alveolar capillaries: neutrophils invade and break their walls (capillaritis), or anti-GBM antibodies bind type IV collagen in the basement membrane → red cells flood the alveoli → shunt and hypoxaemia, falling haemoglobin and diffuse infiltrates; alveolar haemoglobin binds carbon monoxide, so DLCO rises → macrophages digest the red cells into haemosiderin (visible after 48–72 hours) → the same injury in glomerular capillaries gives rapidly progressive glomerulonephritis (pulmonary-renal syndrome) → repeated bleeds can lead to fibrosis.
Classification
- By histology: capillaritis, bland haemorrhage, or diffuse alveolar damage
- Immune (vasculitis, anti-GBM, lupus) versus non-immune (coagulopathy, cardiac, toxic, transplant)
- Isolated lung disease versus pulmonary-renal syndrome
Symptoms and signs
- Breathlessness, often developing over days
- Cough
- Haemoptysis, absent in up to a third of cases
- Fever
- Fatigue and pallor from anaemia
- Features of the cause: sinusitis and nose bleeding (granulomatosis with polyangiitis), rash, arthritis, haematuria or reduced urine output
Diagnosis
- Clinical
- Suspected with diffuse infiltrates, hypoxaemia and anaemia, with or without haemoptysis. The kidneys are always assessed. A rapid search for vasculitis, anti-GBM disease and lupus is urgent because treatment should start before all results are back.
- Tests
- Bronchoscopy with sequential lavage: aliquots that become progressively bloodier confirm haemorrhage; haemosiderin-laden macrophages appear after 48 to 72 hours; cultures exclude infection. Blood count (falling haemoglobin), coagulation, creatinine and urinalysis with microscopy for red cell casts. ANCA (PR3, MPO), anti-GBM antibodies, antinuclear and anti-dsDNA antibodies, complement and antiphospholipid antibodies. DLCO is increased because alveolar blood takes up carbon monoxide, if the patient is stable enough to test. Kidney or lung biopsy confirms vasculitis or linear anti-GBM deposits.
- Imaging
- Chest X-ray: bilateral patchy or diffuse alveolar opacities, often sparing the apices. CT: ground glass and consolidation, sometimes with crazy paving and centrilobular nodules after repeated bleeding; nodules or cavities suggest granulomatosis with polyangiitis. Echocardiography for mitral stenosis or left heart failure.
Differential diagnosis
- Pneumonia (bacterial, viral or opportunistic)
- Cardiogenic pulmonary oedema
- ARDS from another cause
- Bleeding from the airways or a focal source (bronchiectasis, tumour, tuberculosis)
- Pulmonary embolism with infarction
- Drug-induced lung disease
Bleeding into the lungs: which cause?
| Cause | Clues | Key test | Kidney |
|---|---|---|---|
| Granulomatosis with polyangiitis | Sinusitis, nasal crusting, lung nodules or cavities | PR3-ANCA; granulomas on biopsy | Often rapidly progressive glomerulonephritis |
| Microscopic polyangiitis | No upper-airway disease, no granulomas | MPO-ANCA | Often rapidly progressive glomerulonephritis |
| Anti-GBM disease (Goodpasture) | Young men or older adults; smoking raises lung risk | Anti-GBM antibodies; linear IgG on kidney biopsy | Rapidly progressive glomerulonephritis |
| Systemic lupus erythematosus | Young woman with rash, arthritis, serositis | Anti-dsDNA, low complement | Lupus nephritis |
| Bland bleeding: mitral stenosis or coagulopathy | Anticoagulants, low platelets, diastolic murmur | Coagulation tests, echocardiography | Usually normal |
Goal of treatment
Support oxygenation, stop the bleeding by treating the cause, protect kidney function and prevent relapse.
Treatment
- Acute
- Oxygen, non-invasive or invasive ventilation with lung-protective settings, transfusion and correction of coagulopathy; stop anticoagulants and offending drugs.
- Medical
- Immune causes: high-dose intravenous methylprednisolone pulses followed by oral corticosteroids, combined with cyclophosphamide or rituximab for induction.
- Procedure
- Plasma exchange for anti-GBM disease to remove circulating antibodies; it may be considered in severe ANCA-associated vasculitis.
- Procedure
- Bronchoscopy for diagnosis and to clear clots; dialysis when renal failure is severe.
- Medical
- Maintenance therapy (for example rituximab or azathioprine) in vasculitis; supportive care, platelet transfusion and treatment of infection in non-immune causes; Pneumocystis prophylaxis during intense immunosuppression.
- Follow-up
- Close monitoring in intensive care: oxygenation, haemoglobin, kidney function and urine output; later ANCA or anti-GBM titres, kidney function and relapse signs.
Complications
- Acute respiratory failure and death
- End-stage kidney disease in pulmonary-renal syndrome
- Recurrent bleeding with pulmonary fibrosis
- Infections from immunosuppression
- Iron-deficiency anaemia from repeated bleeds
Common traps
- No haemoptysis rules out alveolar haemorrhage: up to a third of patients do not cough blood; falling haemoglobin with new diffuse infiltrates is the clue
- A raised DLCO means healthy lungs: in alveolar haemorrhage, haemoglobin in the air spaces takes up carbon monoxide, so a rising DLCO with infiltrates suggests fresh bleeding
- One bloody lavage sample confirms DAH: the sign is sequential aliquots that get progressively bloodier; a single bloody sample can come from the airway or the bronchoscope
- Treatment waits for ANCA and anti-GBM results: immune DAH is treated as soon as it is suspected and infection is excluded, because delay costs lungs and kidneys
- Alveolar haemorrhage is only a lung problem: always check creatinine and the urine for blood and red cell casts, because a pulmonary-renal syndrome changes urgency and treatment
Prognosis
Serious: in-hospital mortality is high, especially with need for mechanical ventilation or kidney failure. Early immunosuppression and plasma exchange in anti-GBM disease have greatly improved survival. Anti-GBM disease rarely relapses, while ANCA-associated vasculitis often does and needs long-term maintenance therapy.
Test yourself
Think of the answer, then tap the question to see it.
What bronchoalveolar lavage finding confirms diffuse alveolar haemorrhage?
Sequential lavage aliquots that become progressively bloodier; haemosiderin-laden macrophages appear after about two to three days.
Why may DLCO be increased in alveolar haemorrhage?
Haemoglobin in the alveoli takes up carbon monoxide, so measured diffusing capacity rises.
Which antigen do anti-GBM antibodies target in Goodpasture syndrome?
The alpha-3 chain of type IV collagen in the basement membranes of glomeruli and alveoli.
What urgent treatment is added to immunosuppression in anti-GBM disease?
Plasma exchange to remove circulating anti-GBM antibodies.
A 28-year-old smoker has a week of dyspnoea and blood-streaked sputum; haemoglobin fell from 13 to 9 g/dL; bilateral alveolar opacities, rising creatinine, red cell casts. Syndrome and next steps?
Pulmonary-renal syndrome with alveolar haemorrhage. Send ANCA and anti-GBM, bronchoscopy to exclude infection, then start corticosteroid pulses and induction (plus plasma exchange if anti-GBM) without waiting.
In emergency medicine
Connections
Educational information, not medical advice. For any symptom, see a health professional.
Sources: Goodpasture Syndrome (StatPearls (NCBI Bookshelf), 2024); Granulomatosis With Polyangiitis (StatPearls (NCBI Bookshelf), 2024); Pulmonary Hemorrhage (StatPearls (NCBI Bookshelf), 2024).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.

